MassIVE MSV000096568

Complete Public PXD058477

Inhibition of Lysosomal LAMTOR1 Increases Autophagy by Suppressing the MTORC1 Pathway to Ameliorate Lipid Accumulations in MAFLD

Subscribe Comment Convert Spectra Reanalyze Spectra Compare Results Add Reanalysis

Description

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a serious metabolic disorder characterized by fat accumulation in the liver, which can trigger liver inflammation and fibrosis, potentially leading to cirrhosis or liver cancer. Despite many studies on MAFLD over the past decades, the development of effective treatment mechanisms for MAFLD remains unclear due to its complex etiology. Given these limitations, we have focused on the discovery of therapeutic agents and molecular targets for the treatment of MAFLD treatment. In this study, we demonstrated that the natural compound acacetin alleviates MAFLD by regulating autophagy in a rapidly induced steatohepatitis a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) mouse model. In addition, acacetin inhibited lipid accumulation in 3T3-L1 adipocytes through autophagy. To identify the target contributing to the autophagy activity of acacetin, we performed Drug Affinity Responsive Target Stability (DARTS) combined with Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) proteomic analysis, which led to the identification of late endosomal/lysosomal adapter and MAPK and MTOR activator (LAMTOR1), a lysosomal membrane adaptor protein. Binding of acacetin to LAMTOR1 induces the release from the LAMTOR complex, leading to inhibition of mammalian target of rapamycin complex 1 (MTORC1), thereby increasing autophagy and ameliorating metabolic disorders through modulation of the MTORC1/AMPK axis. Furthermore, genetic knockdown of LAMTOR1 induced lysosomal activity and reduced lipid accumulation in cells, confirming that acacetin targets LAMTOR1. Taken together, this study identifies LAMTOR1 as a key protein target of acacetin, a natural anti-MAFLD compound, providing a novel therapeutic approach for the treatment of MAFLD by targeting LAMTOR1. [doi:10.25345/C56M33G26] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: DARTS ; LC-MS/MS ; Lysosome ; Metabolic diseases ; MTORC1

Contact

Principal Investigators:
(in alphabetical order) 		Ho Jeong Kwon, College of Life Science and Biotechnology, Yonsei University, South Korea
Submitting User: juyeon4444
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files Browse Results
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.